These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8295214)

  • 41. Activation of voltage-sensitive sodium channels during oxygen deprivation leads to apoptotic neuronal death.
    Banasiak KJ; Burenkova O; Haddad GG
    Neuroscience; 2004; 126(1):31-44. PubMed ID: 15145071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Butyl 2-(4-[1.1'-biphenyl]-4-yl-1H-imidazol-2-yl)ethylcarbamate, a potent sodium channel blocker for the treatment of neuropathic pain.
    Liberatore AM; Schulz J; Favre-Guilmard C; Pommier J; Lannoy J; Pawlowski E; Barthelemy MA; Huchet M; Auguet M; Chabrier PE; Bigg D
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1746-9. PubMed ID: 17234409
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional characterization of sodium channel blockers by membrane potential measurements in cerebellar neurons: prediction of compound preference for the open/inactivated state.
    Kolok S; Nagy J; Szombathelyi Z; Tarnawa I
    Neurochem Int; 2006 Nov; 49(6):593-604. PubMed ID: 16777267
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vascular smooth muscle contraction induced by Na+ channel activators, veratridine and batrachotoxin.
    Shinjoh M; Nakaki T; Otsuka Y; Sasakawa N; Kato R
    Eur J Pharmacol; 1991 Nov; 205(2):199-202. PubMed ID: 1667387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacological characterization of Na+ influx via voltage-gated Na+ channels in spinal cord astrocytes.
    Rose CR; Ransom BR; Waxman SG
    J Neurophysiol; 1997 Dec; 78(6):3249-58. PubMed ID: 9405543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Short- and long-term differential effects of neuroprotective drug NS-7 on voltage-dependent sodium channels in adrenal chromaffin cells.
    Yokoo H; Shiraishi S; Kobayashi H; Yanagita T; Minami S; Yamamoto R; Wada A
    Br J Pharmacol; 2000 Oct; 131(4):779-87. PubMed ID: 11030728
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological properties of trimebutine and N-monodesmethyltrimebutine.
    Roman FJ; Lanet S; Hamon J; Brunelle G; Maurin A; Champeroux P; Richard S; Alessandri N; Gola M
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1391-7. PubMed ID: 10336531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ca(2+) influx through nonselective cation channels plays an essential role in noradrenaline-induced arachidonic acid release in Chinese hamster ovary cells expressing alpha(1A)-, alpha(1B)-, or alpha(1D)-adrenergic receptors.
    Kawanabe Y; Hashimoto N; Masaki T; Miwa S
    J Pharmacol Exp Ther; 2001 Dec; 299(3):901-7. PubMed ID: 11714874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of sodium ion influx in depolarization-induced neuronal cell death by high KCI or veratridine.
    Takahashi S; Shibata M; Fukuuchi Y
    Eur J Pharmacol; 1999 May; 372(3):297-304. PubMed ID: 10395025
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cannabinoid receptor agonist CP-55,940 and ethyl arachidonate interfere with [(3)H]batrachotoxinin A 20 alpha-benzoate binding to sodium channels and inhibit sodium channel function.
    Duan Y; Liao C; Jain S; Nicholson RA
    Comp Biochem Physiol C Toxicol Pharmacol; 2008 Sep; 148(3):244-9. PubMed ID: 18599378
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [14C]guanidinium ion influx into Na+ channel preparations from mouse cerebral cortex.
    Reith ME
    Eur J Pharmacol; 1990 Jan; 188(1):33-41. PubMed ID: 2155120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sodium channel activators: model of binding inside the pore and a possible mechanism of action.
    Tikhonov DB; Zhorov BS
    FEBS Lett; 2005 Aug; 579(20):4207-12. PubMed ID: 16083886
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incorporation of sodium channel blocking and free radical scavenging activities into a single drug, AM-36, results in profound inhibition of neuronal apoptosis.
    Callaway JK; Beart PM; Jarrott B; Giardina SF
    Br J Pharmacol; 2001 Apr; 132(8):1691-8. PubMed ID: 11309240
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of anticonvulsants on veratridine- and KCl-evoked glutamate release from rat cortical synaptosomes.
    Lingamaneni R; Hemmings HC
    Neurosci Lett; 1999 Dec; 276(2):127-30. PubMed ID: 10624808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vincamine and vincanol are potent blockers of voltage-gated Na+ channels.
    Erdo SA; Molnár P; Lakics V; Bence JZ; Tömösközi Z
    Eur J Pharmacol; 1996 Oct; 314(1-2):69-73. PubMed ID: 8957220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The interaction between the activator agents batrachotoxin and veratridine and the gating processes of neuronal sodium channels.
    Rando TA; Wang GK; Strichartz GR
    Mol Pharmacol; 1986 May; 29(5):467-77. PubMed ID: 2422536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Na+-dependent high affinity binding of [3H]LY515300, a 3,4-dimethyl-4-(3-hydroxyphenyl)piperidine opioid receptor inverse agonist.
    Statnick MA; Suter TM; Gackenheimer SL; Emmerson PJ; Quimby SJ; Gehlert DR; Wheeler WJ; Mitch CH
    Eur J Pharmacol; 2003 Dec; 482(1-3):139-50. PubMed ID: 14660015
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anticonvulsive action of (+/-)-kavain estimated from its properties on stimulated synaptosomes and Na+ channel receptor sites.
    Gleitz J; Friese J; Beile A; Ameri A; Peters T
    Eur J Pharmacol; 1996 Nov; 315(1):89-97. PubMed ID: 8960869
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Up-regulation of functional voltage-dependent sodium channels by insulin in cultured bovine adrenal chromaffin cells.
    Yamamoto R; Yanagita T; Kobayashi H; Yuhi T; Yokoo H; Wada A
    J Neurochem; 1996 Oct; 67(4):1401-8. PubMed ID: 8858921
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, calcium-channel-blocking activity, and antihypertensive activity of 4-(diarylmethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds.
    Shanklin JR; Johnson CP; Proakis AG; Barrett RJ
    J Med Chem; 1991 Oct; 34(10):3011-22. PubMed ID: 1920352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.